Overview

Neoadjuvant Therapy for Locally Advanced Right-sided Colon Cancer

Status:
Recruiting

Trial end date:
2025-11-30

Target enrollment:

Participant gender:

Summary

To determine the Efficacy and Safety of camrelizumab and apatinib combined with chemotherapy (mFOLFOX6) for locally advanced right-sided colon cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Zhejiang University

Treatments:

Apatinib